1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RVL PHARMACEUTICALS PLC
RVL Pharmaceuticals plc XNAS: RVLP

Watchlist

Portfolio

Alert
36.9

Operating Revenue TTM

Below industry Median
-68.3

Net profit TTM

Negative Net profit TTM
-184.9

Net Profit Margin TTM %

5.6

Operating Revenue growth TTM %

Below industry Median
-20.8

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
Board Meeting
The board meeting for RVL Pharmaceuticals plc is scheduled for today, for the purpose of RVL Pharmaceuticals PLC Third Quarter Earnings Conference Call for 2025 See details

RVL Pharmaceuticals plc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents